| Year |
Title |
Altmetric |
| 2019
|
Association of mTOR Pathway Markers and Clinical Outcomes in Patients with Intermediate-/High-risk Prostate Cancer: Long-Term Analysis.
Clinical Genitourinary Cancer.
17:366-372.
2019
|
|
| 2019
|
Correlation between MRI phenotypes and a genomic classifier of prostate cancer: preliminary findings.
European Radiology.
29:4861-4870.
2019
|
|
| 2019
|
Older Age at Diagnosis and Initial Disease Volume Predict Grade Reclassification Risk on Confirmatory Biopsy in Patients Considered for Active Surveillance.
Urology.
130:106-112.
2019
|
|
| 2019
|
Randomized phase II trial of neoadjuvant everolimus in patients with high-risk localized prostate cancer.
Investigational New Drugs.
37:559-566.
2019
|
|
| 2019
|
Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy.
Oncogene.
38:4496-4511.
2019
|
|
| 2019
|
Low Rate of Cancer Events After Partial Nephrectomy for Renal Cell Carcinoma: Clinicopathologic Analysis of 1994 Cases with Emphasis on Definition of “Recurrence”.
Clinical Genitourinary Cancer.
17:209-215.e1.
2019
|
|
| 2019
|
Clinical significance and EZH2, ERG and SPINK1 protein expression in pure and mixed ductal adenocarcinoma of the prostate.
Histology and Histopathology.
34:381-390.
2019
|
|
| 2019
|
Fumarate hydratase deficient renal cell carcinoma: Chromosomal numerical aberration analysis of 12 cases.
Annals of Diagnostic Pathology.
39:63-68.
2019
|
|
| 2019
|
High-grade oncocytic tumour (HOT) of kidney in a patient with tuberous sclerosis complex.
Histopathology.
75:440-442.
2019
|
|
| 2019
|
Transcriptomic and protein analysis of small-cell bladder cancer (SCBC) Identifies prognostic biomarkers and DLL3 as a relevant therapeutic target.
Clinical Cancer Research.
25:210-221.
2019
|
|
| 2018
|
"atrophic Kidney"-like Lesion.
American Journal of Surgical Pathology.
42:1585-1595.
2018
|
|
| 2018
|
Granular Cell Tumor of the Bladder: A Report of Six Cases.
Urology.
121:203.e1-203.e5.
2018
|
|
| 2018
|
IFNL4-ΔG Allele Is Associated with an Interferon Signature in Tumors and Survival of African-American Men with Prostate Cancer.
Clinical Cancer Research.
24:5471-5481.
2018
|
|
| 2018
|
Immunohistochemical Pitfalls in Genitourinary Pathology: 2018 Update.
Advances in Anatomic Pathology.
25:387-399.
2018
|
|
| 2018
|
The 17-Gene Genomic Prostate Score Assay Predicts Outcome After Radical Prostatectomy Independent of PTEN Status.
Urology.
121:132-138.
2018
|
|
| 2018
|
Acquired cystic disease-associated renal cell carcinoma (ACD-RCC): A multiinstitutional study of 40 cases with clinical follow-up.
American Journal of Surgical Pathology.
42:1156-1165.
2018
|
|
| 2018
|
Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? A multi-center, multi-reader investigation.
Oncotarget.
9:33804-33817.
2018
|
|
| 2018
|
Unfavorable pathology, tissue biomarkers and genomic tests with clinical implications in prostate cancer management.
Advances in Anatomic Pathology.
25:293-303.
2018
|
|
| 2018
|
Prognostic Factors and Risk Stratification in Invasive Upper Tract Urothelial Carcinoma.
Clinical Genitourinary Cancer.
16:e751-e760.
2018
|
|
| 2018
|
SWI/SNF protein expression status in fumarate hydratase–deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients.
Human Pathology.
77:139-146.
2018
|
|
| 2018
|
Utility of Pathology Imagebase for standardisation of prostate cancer grading.
Histopathology.
73:8-18.
2018
|
|
| 2018
|
Eosinophilic solid and cystic renal cell carcinomas have metastatic potential.
Histopathology.
72:1066-1067.
2018
|
|
| 2018
|
Features and Prognostic Significance of Intraductal Carcinoma of the Prostate.
European Urology Oncology.
1:21-28.
2018
|
|
| 2018
|
Biphasic papillary renal cell carcinoma is a rare morphological variant with frequent multifocality: a study of 28 cases.
Histopathology.
72:777-785.
2018
|
|
| 2018
|
Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical Prostatectomy.
Journal of Urology, The.
199:719-725.
2018
|
|
| 2018
|
Genomic Scores are Independent of Disease Volume in Men with Favorable Risk Prostate Cancer: Implications for Choosing Men for Active Surveillance.
Journal of Urology, The.
199:438-444.
2018
|
|
| 2018
|
Impact of 5α-Reductase Inhibitors on Disease Reclassification among Men on Active Surveillance for Localized Prostate Cancer with Favorable Features.
Journal of Urology, The.
199:445-452.
2018
|
|
| 2018
|
Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: Systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays.
Modern Pathology.
31:179-197.
2018
|
|
| 2018
|
PTEN Expression in Mucinous Prostatic Adenocarcinoma, Prostatic Adenocarcinoma with Mucinous Features, and Adjacent Conventional Prostatic Adenocarcinoma: A Multi-institutional Study of 92 Cases.
Applied Immunohistochemistry and Molecular Morphology.
26:225-230.
2018
|
|
| 2018
|
Prostate cancer: diagnostic criteria and role of immunohistochemistry.
Modern Pathology.
31:S12-S21.
2018
|
|
| 2018
|
Reappraisal of Morphologic Differences between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.
American Journal of Surgical Pathology.
42:279-292.
2018
|
|
| 2017
|
Pathology Imagebase—a reference image database for standardization of pathology.
Histopathology.
71:677-685.
2017
|
|
| 2017
|
Direct metabolic interrogation of dihydrotestosterone biosynthesis from adrenal precursors in primary prostatectomy tissues.
Clinical Cancer Research.
23:6351-6363.
2017
|
|
| 2017
|
A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer.
eLife.
6.
2017
|
|
| 2017
|
Programmed death-1 (PD-1) receptor/PD-1 ligand (PD-L1) expression in fumarate hydratase-deficient renal cell carcinoma.
Annals of Diagnostic Pathology.
29:17-22.
2017
|
|
| 2017
|
Reporting and staging of testicular germ cell tumors: The international society of urological pathology (ISUP) testicular cancer consultation conference recommendations.
American Journal of Surgical Pathology.
41:e22-e32.
2017
|
|
| 2017
|
Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI.
Bioconjugate Chemistry.
28:1031-1040.
2017
|
|
| 2017
|
Squamous cell carcinoma of the bladder complicating schistosomiasis.
Radiographics.
37:500-504.
2017
|
|
| 2017
|
The World Health Organization 2016 classification of testicular non-germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel.
Histopathology.
70:513-521.
2017
|
|
| 2017
|
Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer.
eLife.
6.
2017
|
|
| 2017
|
The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel.
Histopathology.
70:335-346.
2017
|
|
| 2017
|
Robot-assisted ureteral reconstruction using a tubularized peritoneal flap: a novel technique in a chronic porcine model.
World Journal of Urology.
35:89-96.
2017
|
|
| 2017
|
Small cell-like glandular proliferation of prostate: a rare lesion not related to small cell prostate cancer.
Virchows Archiv.
470:47-54.
2017
|
|
| 2017
|
Upper tract urothelial carcinomas: Frequency of association with mismatch repair protein loss and lynch syndrome.
Modern Pathology.
30:146-156.
2017
|
|
| 2016
|
HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study.
Lancet Oncology.
17:1435-1444.
2016
|
|
| 2016
|
Tubulocystic carcinoma of the kidney with poorly differentiated foci.
American Journal of Surgical Pathology.
40:1457-1472.
2016
|
|
| 2016
|
Contemporary Gleason grading and novel Grade Groups in clinical practice.
Current Opinion in Urology.
26:488-492.
2016
|
|
| 2016
|
Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists.
Histopathology.
69:441-449.
2016
|
|
| 2016
|
Tumor Necrosis Adds Prognostically Significant Information to Grade in Clear Cell Renal Cell Carcinoma: A Study of 842 Consecutive Cases from a Single Institution.
American Journal of Surgical Pathology.
40:1224-1231.
2016
|
|
| 2016
|
PTEN Expression in Mucinous Prostatic Adenocarcinoma, Prostatic Adenocarcinoma With Mucinous Features, and Adjacent Conventional Prostatic Adenocarcinoma: A Multiinstitutional Study of 92 Cases..
Applied Immunohistochemistry and Molecular Morphology.
2016
|
|
| 2016
|
Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: Evidence for a biologically meaningful field effect.
Oncotarget.
7:33855-33865.
2016
|
|
| 2016
|
Malakoplakia associated with prostatic adenocarcinoma Report of 4 cases and literature review.
Annals of Diagnostic Pathology.
22:33-37.
2016
|
|
| 2016
|
Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation.
Oncotarget.
7:29901-29915.
2016
|
|
| 2016
|
Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer.
EBioMedicine.
7:85-93.
2016
|
|
| 2016
|
Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk.
Urology.
90:148-152.
2016
|
|
| 2016
|
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.
European Urology.
69:428-435.
2016
|
|
| 2016
|
Eosinophilic, solid, and cystic renal cell carcinoma.
American Journal of Surgical Pathology.
40:60-71.
2016
|
|
| 2016
|
Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome.
American Journal of Surgical Pathology.
40:865-875.
2016
|
|
| 2016
|
Renal cell carcinoma occurring in patients with prior neuroblastoma.
American Journal of Surgical Pathology.
40:989-997.
2016
|
|
| 2016
|
Renal neoplasms with overlapping features of clear cell renal cell carcinoma and clear cell papillary renal cell carcinoma a clinicopathologic study of 37 cases from a single institution.
American Journal of Surgical Pathology.
40:141-154.
2016
|
|
| 2015
|
Diagnosis of "poorly formed glands" Gleason pattern 4 prostatic adenocarcinoma on needle biopsy: An interobserver reproducibility study among urologic pathologists with recommendations.
American Journal of Surgical Pathology.
39:1331-1339.
2015
|
|
| 2015
|
Novel biomarkers and genomic tests in prostate cancer: A critical analysis.
Minerva Urologica e Nefrologica.
67:211-231.
2015
|
|
| 2015
|
Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance?.
BJU International.
116:220-229.
2015
|
|
| 2015
|
The TMPRSS2-ERG gene fusion blocks XRCC4-mediated nonhomologous end-joining repair and radiosensitizes prostate cancer cells to PARP inhibition.
Molecular Cancer Therapeutics.
14:1896-1906.
2015
|
|
| 2015
|
Biology of Human Tumors Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancer.
Clinical Cancer Research.
21:2591-2600.
2015
|
|
| 2015
|
EDB fibronectin specific peptide for prostate cancer targeting.
Bioconjugate Chemistry.
26:830-838.
2015
|
|
| 2015
|
A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
European Urology.
67:778-786.
2015
|
|
| 2015
|
A genomic algorithm for the molecular classification of common renal cortical neoplasms: Development and validation.
Journal of Urology, The.
193:1479-1485.
2015
|
|
| 2015
|
Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.
European Urology.
68:555-567.
2015
|
|
| 2015
|
Handling and reporting of orchidectomy specimens with testicular cancer: Areas of consensus and variation among 25 experts and 225 European pathologists.
Histopathology.
67:313-324.
2015
|
|
| 2015
|
Metastatic prostate adenocarcinoma to the penis presenting as pagetoid carcinoma.
American Journal of Surgical Pathology.
39:724-726.
2015
|
|
| 2015
|
Methylome-wide Sequencing Detects DNA Hypermethylation Distinguishing Indolent from Aggressive Prostate Cancer.
Cell Reports.
13:2135-2146.
2015
|
|
| 2015
|
MicroRNA in prostate cancer: Practical aspects.
Histology and Histopathology.
30:1379-1396.
2015
|
|
| 2015
|
Renal leiomyoma: A contemporary multi-institution study of an infrequent and frequently misclassified neoplasm.
American Journal of Surgical Pathology.
39:349-356.
2015
|
|
| 2015
|
Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer.
Modern Pathology.
28:612-630.
2015
|
|
| 2015
|
Upper tract urinary cytology to detect upper tract urothelial carcinoma: Using the Johns Hopkins Hospital template and evaluation of its feasibility.
CytoJournal.
12.
2015
|
|
| 2015
|
Urinary bladder xanthoma: A multi-institutional series of 17 cases.
Histopathology.
67:255-261.
2015
|
|
| 2015
|
Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from Intraductal Carcinoma of the Prostate on Needle Biopsy.
American Journal of Surgical Pathology.
39:169-178.
2015
|
|
| 2014
|
Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies.
Journal of Urology, The.
192:1081-1087.
2014
|
|
| 2014
|
Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin).
Molecular Cancer.
13.
2014
|
|
| 2014
|
A 17-gene assay to predict prostate cancer aggressiveness in the context of gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
European Urology.
66:550-560.
2014
|
|
| 2014
|
Diagnostic criteria for ductal adenocarcinoma of the prostate: Interobserver variability among 20 expert uropathologists.
Histopathology.
65:216-227.
2014
|
|
| 2014
|
Epithelial-to-mesenchymal transition in renal neoplasms.
Advances in Anatomic Pathology.
21:174-180.
2014
|
|
| 2014
|
Intraductal carcinoma of the prostate: Interobserver reproducibility survey of 39 urologic pathologists.
Annals of Diagnostic Pathology.
18:333-342.
2014
|
|
| 2014
|
RNA biomarkers associated with metastatic progression in prostate cancer: A multi-institutional high-throughput analysis of SChLAP1.
Lancet Oncology.
15:1469-1480.
2014
|
|
| 2014
|
Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations.
Annales de Pathologie.
34:448-461.
2014
|
|
| 2014
|
Rhabdoid differentiation is associated with aggressive behavior in renal cell carcinoma: A clinicopathologic analysis of 76 cases with clinical follow-up.
American Journal of Surgical Pathology.
38:1260-1265.
2014
|
|
| 2014
|
Succinate dehydrogenase (SDH)-deficient renal carcinoma: A morphologically distinct entity: A clinicopathologic series of 36 tumors from 27 patients.
American Journal of Surgical Pathology.
38:1588-1602.
2014
|
|
| 2014
|
Tuberous sclerosis-associated renal cell carcinoma: A clinicopathologic study of 57 separate carcinomas in 18 patients.
American Journal of Surgical Pathology.
38:1457-1467.
2014
|
|
| 2013
|
ERG protein expression as a biomarker of prostate cancer.
Biomarkers in Medicine.
7:851-865.
2013
|
|
| 2013
|
Prediction of prostate cancer to urethra distance by a pretreatment nomogram: Urethral thermoprotection implication in cryoablation.
Prostate Cancer and Prostatic Diseases.
16:372-375.
2013
|
|
| 2013
|
Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsies.
BMC Genomics.
14.
2013
|
|
| 2013
|
Incidence and clinicopathological characteristics of intraductal carcinoma detected in prostate biopsies: A prospective cohort study.
Histopathology.
63:574-579.
2013
|
|
| 2013
|
Hereditary syndromes with associated renal neoplasia: A practical guide to histologic recognition in renal tumor resection specimens.
Advances in Anatomic Pathology.
20:245-263.
2013
|
|
| 2013
|
Prostate cancer patients older than 70 years treated by radical prostatectomy have higher biochemical recurrence rate than their matched younger counterpart.
Prostate.
73:897-903.
2013
|
|
| 2013
|
Metanephric adenoma and solid variant of papillary renal cell carcinoma: Common and distinctive features.
Histopathology.
62:941-953.
2013
|
|
| 2013
|
A 45-year-old with neuroendocrine carcinoma of the prostate.
Urology.
81:714-716.
2013
|
|
| 2013
|
Intraductal carcinoma of the prostate: Precursor or aggressive phenotype of prostate cancer?.
Prostate.
73:442-448.
2013
|
|
| 2013
|
Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1.
Cancer Research.
73:1211-1218.
2013
|
|
| 2013
|
Handling and staging of renal cell carcinoma: The International Society of Urological Pathology Consensus (ISUP) conference recommendations.
American Journal of Surgical Pathology.
37:1505-1517.
2013
|
|
| 2013
|
Metastatic papillary thyroid carcinoma to the kidney: Report of two cases mimicking primary renal cell carcinoma and review of the literature.
Pathology.
45:89-93.
2013
|
|
| 2013
|
Renal tumors: Diagnostic and prognostic biomarkers.
American Journal of Surgical Pathology.
37:1518-1531.
2013
|
|
| 2013
|
Robotic real-time near infrared targeted fluorescence imaging in a murine model of prostate cancer: A feasibility study.
Urology.
81:451-457.
2013
|
|
| 2013
|
The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia.
American Journal of Surgical Pathology.
37:1469-1489.
2013
|
|
| 2013
|
The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters.
American Journal of Surgical Pathology.
37:1490-1504.
2013
|
|
| 2012
|
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent.
Science.
338:1465-1469.
2012
|
|
| 2012
|
ERG protein expression in human tumors detected with a rabbit monoclonal antibody.
American Journal of Clinical Pathology.
138:803-810.
2012
|
|
| 2012
|
Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): Lack of utility to stratify cancer risks associated with HGPIN.
BJU International.
110.
2012
|
|
| 2012
|
Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: Implications for focal therapy.
Prostate.
72:1179-1186.
2012
|
|
| 2012
|
A contemporary update on pathology reporting for prostate cancer: Biopsy and radical prostatectomy specimens.
European Urology.
62:20-39.
2012
|
|
| 2012
|
High-Grade prostatic intraepithelial neoplasia.
Taehan Pinyuki Kwahak Hoe-ji.
53:297-303.
2012
|
|
| 2012
|
Intraductal carcinoma of the prostate.
Archives of Pathology and Laboratory Medicine.
136:418-425.
2012
|
|
| 2011
|
Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature.
Modern Pathology.
24:1521-1529.
2011
|
|
| 2011
|
ERG gene rearrangement status in prostate cancer detected by immunohistochemistry.
Virchows Archiv.
459:441-447.
2011
|
|
| 2011
|
PAX8 and PAX2 immunostaining facilitates the diagnosis of primary epithelial neoplasms of the male genital tract.
American Journal of Surgical Pathology.
35:1473-1483.
2011
|
|
| 2011
|
Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
American Journal of Surgical Pathology.
35:1134-1139.
2011
|
|
| 2011
|
International society of urological pathology consensus conference on handling and staging of radical prostatectomy specimens.
Advances in Anatomic Pathology.
18:301-305.
2011
|
|
| 2011
|
The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies.
American Journal of Surgical Pathology.
35:1062-1068.
2011
|
|
| 2011
|
TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients.
Prostate.
71:489-497.
2011
|
|
| 2011
|
The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer".
American Journal of Surgical Pathology.
35:608-614.
2011
|
|
| 2011
|
Prostate cancer staging and grading at radical prostatectomy over time.
Advances in Anatomic Pathology.
18:159-164.
2011
|
|
| 2011
|
Single focus prostate cancer: Pathological features and erg fusion status.
Journal of Urology, The.
185:489-494.
2011
|
|
| 2011
|
Adenomatoid tumour of the adrenal gland in a patient with germline SDHD mutation: A case report and review of the literature.
Pathology.
43:495-498.
2011
|
|
| 2011
|
International society of urological pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. working group 3: Extraprostatic extension, lymphovascular invasion and locally advanced disease.
Modern Pathology.
24:26-38.
2011
|
|
| 2011
|
Pathology update for urologists..
Prostate Cancer.
2011:183761.
2011
|
|
| 2011
|
The Epstein criteria predict for organ-confined but not insignificant disease and a high likelihood of cure at radical prostatectomy.
International Brazilian Journal of Urology.
37:123.
2011
|
|
| 2010
|
Clear cell tubulopapillary renal cell carcinoma: A study of 36 distinctive low-grade epithelial tumors of the kidney.
American Journal of Surgical Pathology.
34:1608-1621.
2010
|
|
| 2010
|
ERG rearrangement is present in a subset of transition zone prostatic tumors.
Modern Pathology.
23:1499-1506.
2010
|
|
| 2010
|
Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer.
Journal of Urology, The.
184:1958-1962.
2010
|
|
| 2010
|
Renal cell carcinomas with intratumoral fat and concomitant angiomyolipoma: Potential pitfalls in staging and diagnosis.
American Journal of Clinical Pathology.
134:807-812.
2010
|
|
| 2010
|
Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: A correlative study and implications for focal therapy.
Urology.
76:682-687.
2010
|
|
| 2010
|
Reply.
Urology.
76:687-688.
2010
|
|
| 2010
|
Staging prostate cancer and its relationship to prognosis.
Diagnostic Histopathology.
16:432-438.
2010
|
|
| 2010
|
The Epstein Criteria Predict for Organ-Confined But Not Insignificant Disease and a High Likelihood of Cure at Radical Prostatectomy.
European Urology.
58:90-95.
2010
|
|
| 2010
|
Importance of Additional "Extreme" Anterior Apical Needle Biopsies in the Initial Detection of Prostate Cancer.
Urology.
75:1034-1039.
2010
|
|
| 2010
|
Atypical cribriform lesions of the prostate: Relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies.
American Journal of Surgical Pathology.
34:470-477.
2010
|
|
| 2010
|
ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia.
American Journal of Surgical Pathology.
34:478-485.
2010
|
|
| 2010
|
Third prize: Synchronized real-time ultrasonography and three-dimensional computed tomography scan navigation during percutaneous renal cryoablation in a porcine model.
Journal of Endourology and Part B, Videourology.
24:333-337.
2010
|
|
| 2010
|
Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: Implications for clinical management.
BJU International.
105:476-480.
2010
|
|
| 2010
|
Clinicopathological features of prostate cancers detected after an initial diagnosis of 'atypical glands suspicious for cancer'.
Pathology.
42:334-338.
2010
|
|
| 2010
|
Editorial Comment.
Journal of Urology, The.
183:157.
2010
|
|
| 2009
|
Are prostate needle biopsies predictive of the laterality of significant cancer and positive surgical margins?.
BJU International.
104:1599-1603.
2009
|
|
| 2009
|
Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: Implications for pathologic classification.
American Journal of Surgical Pathology.
33:1840-1849.
2009
|
|
| 2009
|
KTP Laser Nerve Sparing Radical Prostatectomy: Comparison of Ultrasonic and Cold Scissor Dissection on Cavernous Nerve Function.
Journal of Urology, The.
181:2760-2766.
2009
|
|
| 2009
|
Phase II Trial of Neoadjuvant Nab-Paclitaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy.
Journal of Urology, The.
181:1672-1677.
2009
|
|
| 2009
|
Renal angiomyolipoma: Clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association.
American Journal of Surgical Pathology.
33:289-297.
2009
|
|
| 2009
|
Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney are the same disease entity: Molecular and histologic evidence.
American Journal of Surgical Pathology.
33:72-80.
2009
|
|
| 2009
|
Microscopic bladder neck involvement by prostate carcinoma in radical prostatectomy specimens is not a significant independent prognostic factor.
Modern Pathology.
22:385-392.
2009
|
|
| 2008
|
Low Testosterone and Risk of Biochemical Recurrence and Poorly Differentiated Prostate Cancer at Radical Prostatectomy.
Urology.
72:1240-1245.
2008
|
|
| 2008
|
Prostatic Adenocarcinoma, Prostatic Intraepithelial Neoplasia, and Intraductal Carcinoma.
Surgical Pathology Clinics.
1:43-75.
2008
|
|
| 2008
|
Urothelial Carcinoma and its Variants.
Surgical Pathology Clinics.
1:159-209.
2008
|
|
| 2008
|
Pathologic characteristics of solitary small renal masses: Can they be predicted by preoperative clinical parameters?.
American Journal of Clinical Pathology.
130:560-564.
2008
|
|
| 2008
|
Laser robotically assisted nerve-sparing radical prostatectomy: A pilot study of technical feasibility in the canine model.
BJU International.
102:598-602.
2008
|
|
| 2008
|
The distinction of bronchogenic cyst from metastatic testicular teratoma: A light microscopic and immunohistochemical study.
American Journal of Clinical Pathology.
130:265-273.
2008
|
|
| 2008
|
Adult Cystic Nephroma and Mixed Epithelial and Stromal Tumor of the Kidney: Clinical, Radiographic, and Pathologic Characteristics.
Urology.
71:1142-1148.
2008
|
|
| 2008
|
Clinical and biological effects of neoadjuvant sargramostim and thalidomide in patients with locally advanced prostate carcinoma.
Clinical Cancer Research.
14:3052-3059.
2008
|
|
| 2008
|
Saturation Technique Does Not Decrease Cancer Detection During Followup After Initial Prostate Biopsy.
Journal of Urology, The.
179:1746-1750.
2008
|
|
| 2008
|
Pathological Aggressiveness of Prostatic Carcinomas Related to RNASEL R462Q Allelic Variants.
Journal of Urology, The.
179:1344-1348.
2008
|
|
| 2008
|
Renal cell carcinomas with papillae.
Revista Española de Patología.
41:99-107.
2008
|
|
| 2008
|
Prostate Cancer Volume at Biopsy Predicts Clinically Significant Upgrading.
Journal of Urology, The.
179:896-900.
2008
|
|
| 2007
|
Parasagittal biopsies are more important as part of an initial biopsy strategy than as part of a repeat biopsy strategy: Observations from a unique population.
Prostate Cancer and Prostatic Diseases.
10:352-355.
2007
|
|
| 2007
|
Pathological evidence of necrosis in recurrent renal mass following treatment with sunitinib.
International Journal of Urology.
14:1095-1097.
2007
|
|
| 2007
|
Pathologic Stage Migration Has Slowed in the Late PSA Era.
Urology.
70:839-842.
2007
|
|
| 2007
|
Renal neuroendocrine tumours: A clinicopathological study.
BJU International.
100:1030-1035.
2007
|
|
| 2007
|
Preoperative PSA Is Still Predictive of Cancer Volume and Grade in Late PSA Era.
Urology.
70:711-716.
2007
|
|
| 2007
|
Neoadjuvant docetaxel treatment for locally advanced prostate cancer: A clinicopathologic study.
Cancer.
110:1248-1254.
2007
|
|
| 2007
|
Tumor Volume Does Not Predict for Biochemical Recurrence After Radical Prostatectomy in Patients with Surgical Gleason Score 6 or Less Prostate Cancer.
Urology.
70:294-298.
2007
|
|
| 2007
|
Erratum: A working group classification of focal prostate atrophy lesions (American Journal of Surgical Pathology (2006) 30, (1281-1291)).
American Journal of Surgical Pathology.
31:652.
2007
|
|
| 2007
|
The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
BJU International.
99:770-774.
2007
|
|
| 2007
|
Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas.
Archives of Pathology and Laboratory Medicine.
131:122-125.
2007
|
|
| 2007
|
The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: A call for standardized methods for immunohistochemical evaluation.
Clinical Genitourinary Cancer.
5:264-270.
2007
|
|
| 2006
|
Erratum: A working group classification of focal prostate atrophy lesions (American Journal of Surgical Pathology (2006) 30 (1281-1291)).
American Journal of Surgical Pathology.
30:1489.
2006
|
|
| 2006
|
A working group classification of focal prostate atrophy lesions.
American Journal of Surgical Pathology.
30:1281-1291.
2006
|
|
| 2006
|
Mucinous adenocarcinoma of the prostate does not confer poor prognosis.
Urology.
68:825-830.
2006
|
|
| 2006
|
Prostate basal cell lesions can be negative for basal cell keratins: A diagnostic pitfall.
Analytical and Quantitative Cytology and Histology.
28:125-129.
2006
|
|
| 2006
|
Real-time transrectal ultrasound guidance during laparoscopic radical prostatectomy: Impact on surgical margins.
Journal of Urology, The.
175:1304-1310.
2006
|
|
| 2006
|
Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.
PLoS Pathogens.
2:0211-0225.
2006
|
|
| 2006
|
Peritumoral lymphatic invasion is associated with regional lymph node metastases in prostate adenocarcinoma.
Modern Pathology.
19:392-398.
2006
|
|
| 2006
|
Saturation technique does not improve cancer detection as an initial prostate biopsy strategy.
Journal of Urology, The.
175:485-488.
2006
|
|
| 2006
|
Non-small cell lung carcinoma metastatic to the kidney..
Canadian Journal of Urology.
13:3281-3282.
2006
|
|
| 2005
|
Laparoscopic partial nephrectomy for cystic masses.
Journal of Urology, The.
174:614-619.
2005
|
|
| 2005
|
Local recurrence of prostate cancer in rectal submucosa after transrectal needle biopsy and radical prostatectomy.
Urology.
66:881.e7-881.e9.
2005
|
|
| 2005
|
Potassium-titanyl-phosphate laser laparoscopic partial nephrectomy without hilar clamping in the survival calf model.
Journal of Urology, The.
174:1110-1114.
2005
|
|
| 2005
|
The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms.
Clinics in Laboratory Medicine.
25:247-257.
2005
|
|
| 2005
|
Water jet assisted laparoscopic partial nephrectomy without hilar clamping in the calf model.
Journal of Urology, The.
174:317-321.
2005
|
|
| 2004
|
ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladder.
American Journal of Surgical Pathology.
28:1609-1614.
2004
|
|
| 2004
|
Urothelial papilloma of the bladder: A review of 34 de novo cases.
American Journal of Surgical Pathology.
28:1615-1620.
2004
|
|
| 2004
|
Laparoscopic extended pelvic lymphadenectomy for bladder cancer: technique and initial outcomes..
Journal of Urology, The.
172:1809-1812.
2004
|
|
| 2004
|
Continuing trends in pathological stage migration in radical prostatectomy specimens.
Urologic Oncology: Seminars and Original Investigations.
22:300-306.
2004
|
|
| 2004
|
Phase II trial of neoadjuvant docetaxel before radical prostatectomy for locally advanced prostate cancer.
Urology.
63:1138-1142.
2004
|
|
| 2004
|
The Prognostic Significance of Tertiary Gleason Pattern 5 in Radical Prostatectomy Specimens.
American Journal of Surgical Pathology.
28:394-398.
2004
|
|
| 2004
|
Laparoscopic extended pelvic lymphadenectomy for bladder cancer: Technique and initial outcomes.
Journal of Urology, The.
172:1809-1812.
2004
|
|
| 2003
|
Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy..
American Journal of Surgical Pathology.
27:1128-1133.
2003
|
|
| 2003
|
α-methylacyl-CoA racemase: A variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy.
American Journal of Surgical Pathology.
27:1128-1133.
2003
|
|
| 2003
|
Atypia in nonneoplastic prostate glands after radiotherapy for prostate cancer: Duration of atypia and relation to type of radiotherapy.
American Journal of Surgical Pathology.
27:206-212.
2003
|
|
| 2003
|
Threshold for Diagnosing Prostate Cancer over Time.
Human Pathology.
34:1116-1118.
2003
|
|
| 2002
|
Predictors of lymph node metastasis in T1 breast carcinoma, stratified by patient age.
Breast Journal.
8:349-355.
2002
|
|
| 1999
|
Demonstrability of the glycoprotein A-80 in postradiation prostatic carcinoma.
Human Pathology.
30:1474-1478.
1999
|
|
| 1998
|
Mitogen-activated protein kinases and apoptosis in PIN.
Virchows Archiv.
432:407-413.
1998
|
|
| 1998
|
Automated in situ hybridization: Diagnostic and research applications.
Diagnostic Molecular Pathology.
7:69-75.
1998
|
|
| 1997
|
Heterogeneity of androgen receptor content in advanced prostate cancer.
Modern Pathology.
10:839-845.
1997
|
|
| 1997
|
The cell cycle inhibitor p27 is an independent prognostic marker in small (T(1a,b)) invasive breast carcinomas.
Cancer Research.
57:1259-1263.
1997
|
|
| 1997
|
Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis.
Laboratory Investigation.
76:37-51.
1997
|
|
| 1996
|
Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis.
American Journal of Pathology.
149:1553-1564.
1996
|
|
| 1996
|
Effect of microwave oven heating times on androgen receptor antigen retrieval from paraffin-embedded prostatic adenocarcinoma.
Anticancer Research.
16:2931-2936.
1996
|
|
| 1996
|
Effect of microwave oven heating times on androgen receptor antigen retrieval from paraffin-embedded prostatic adenocarcinoma..
Anticancer Research.
16:2931-2936.
1996
|
|
| 1996
|
Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the noble rat model of sex hormone-induced prostatic dysplasia and carcinoma.
Laboratory Investigation.
75:361-370.
1996
|
|
| 1996
|
Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia.
Anticancer Research.
16:2057-2062.
1996
|
|
| 1996
|
Molecular events in the early phases of prostate carcinogenesis.
European Urology.
30:167-176.
1996
|
|
| 1995
|
Apoptotic Bodies in Prostatic Intraepithelial Neoplasia and Prostatic Adenocarcinoma Following Total Androgen Ablation.
Pathology - Research and Practice.
191:873-880.
1995
|
|
| 1994
|
Effects of combination endocrine treatment on normal prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma.
Journal of Clinical Pathology.
47:906-913.
1994
|
|
| 1994
|
Morphometrically assisted grading of astrocytomas.
Analytical and Quantitative Cytology and Histology.
16:351-356.
1994
|
|
| 1994
|
Quantitative evaluation of nucleolar features on cytologic material in brain tumor diagnosis.
Clinical Neuropathology.
13:323-328.
1994
|
|
| 1993
|
Frequency and location of mitoses in prostatic intraepithelial neoplasia (PIN).
Anticancer Research.
13:2447-2451.
1993
|
|
| 1993
|
Occurrence of cell death (apoptosis) in prostatic intra-epithelial neoplasia.
Virchows Archiv. A, Pathological anatomy and histopathology.
423:351-357.
1993
|
|
| 1993
|
Prostatic intra-epithelial neoplasia: Expression and location of proliferating cell nuclear antigen in epithelial, endothelial and stromal nuclei.
Virchows Archiv. A, Pathological anatomy and histopathology.
422:185-192.
1993
|
|
| 1993
|
Computed cell cycle and DNA histogram analyses in image cytometry in breast cancer.
Journal of Clinical Pathology.
46:795-800.
1993
|
|
| 1993
|
Proliferating Cell Nuclear Antigen (PCNA) evaluation in the diagnostic quantitative pathology of cribriform adenocarcinoma of the prostate.
In Vivo.
7:343-346.
1993
|
|
| 1993
|
Proliferating cell nuclear antigen (PCNA) in prostatic invasive adenocarcinoma. Is the proliferation state in the marginal zone of the tumour higher than in the central part?.
Anticancer Research.
13:129-132.
1993
|
|
| 1993
|
Prostatic Intra-epithelial Neoplasia: Qualitative and Quantitative Analyses of the Blood Capillary Architecture on Thin Tissue Sections.
Pathology - Research and Practice.
189:542-548.
1993
|
|
| 1993
|
Prostatic Invasive Adenocarcinoma: Effect of Combination Endocrine Therapy (LHRH Agonist and Flutamide) on the Expression and Location of Proliferating Cell Nuclear Antigen (PCNA).
Pathology - Research and Practice.
189:1154-1160.
1993
|
|
| 1992
|
Aneuploidy and nuclear features of prostatic intraepithelial neoplasia (PIN).
Journal of Cellular Biochemistry.
50:47-53.
1992
|
|
| 1992
|
Quantitative analysis of quadriceps muscle biopsy in systemic sclerosis.
Pathology - Research and Practice.
188:603-606.
1992
|
|
| 1991
|
Quantitative analysis of nucleolar margination in diagnostic cytopathology.
Virchows Archiv. A, Pathological anatomy and histopathology.
419:505-512.
1991
|
|
| |
Correction: A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer..
eLife.
6.
|
|
